The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Enzalutamide versus abiraterone plus prednisolone before chemotherapy for Japanese castration-resistant prostate cancer patients: An investigator-initiated, multicenter, randomized controlled trial.
 
Kouji Izumi
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; MSD; Nippon Covidien; Ono Pharmaceutical
Research Funding - AstraZeneca; Chugai Pharma; MSD
Expert Testimony - Bayer
 
Takashi Shima
No Relationships to Disclose
 
Koji Mita
No Relationships to Disclose
 
Yuki Kato
No Relationships to Disclose
 
Manabu Kamiyama
No Relationships to Disclose
 
Shogo Inoue
No Relationships to Disclose
 
Nobumichi Tanaka
No Relationships to Disclose
 
Seiji Hoshi
No Relationships to Disclose
 
Takehiko Okamura
No Relationships to Disclose
 
Yuko Yoshio
No Relationships to Disclose
 
Hideki Enokida
No Relationships to Disclose
 
Ippei Chikazawa
No Relationships to Disclose
 
Noriyasu Kawai
No Relationships to Disclose
 
Kohei Hashimoto
No Relationships to Disclose
 
Takashi Fukagai
No Relationships to Disclose
 
Kazuyoshi Shigehara
No Relationships to Disclose
 
Shizuko Takahara
No Relationships to Disclose
 
Yoshifumi Kadono
No Relationships to Disclose
 
Atsushi Mizokami
No Relationships to Disclose